Olympus reviewed the following literature article: "utility of radial incision and cutting with steroid injection for refractory stricture after endoscopic submucosal dissection for large superficial esophageal squamous cell carcinoma" by jingyuan xiang.
this retrospective study was aimed to perform radial incision and cutting (ric) combined with steroid use to treat post- endoscopic submucosal dissection (esd) refractory stricture.
Considering the systematic adverse events of oral administration, a local steroid injection is conducted during operation.
The study enrolled 25 patients who accepted repeated endoscopic balloon dilation (ebd) because of refractory stricture after extensive esd for large superficial esophagus squamous cell carcinoma (sescc).
The primary endpoints of the study were the incidence of recurrent stricture while the secondary endpoint was the following therapeutic ebd outcome, evaluated mainly by mean symptom-relief duration (msd) and valid symptom-relief period (vsp).
The study reported that during the follow-up, the incidence of recurrent esophageal strictures was 92%, and perforation was observed in one patient.
The study concluded that a combination of radial incision and cutting with steroid injection is a safe and feasible treatment for esophageal refractory stricture after extensive esd.
Type of adverse events: stricture recurred: (n = 23); intra-operation perforation: (1) one patient was found intra-operation perforation and the incidence of procedure-related adverse events was 4%.
In this case, 8 ebd treatments had been performed in the past 163 days before combined treatment and tough fibrosis scar formed with severe adhesion.
Perforation was sealed by several metal clips successfully and healed well under the follow-up endoscopy.
Median number of 4 (median 0¿9) following ebd sessions were carried out for recurring dysphagia.
This article includes 5 reports: patient identifier (b)(6): ucr; patient identifier (b)(6): kd-620lr; patient identifier (b)(6): gif-q260j; patient identifier (b)(6): fd-410lr; patient identifier (b)(6): nm-200l-0425.
This report is 4 of 5 for patient identifier (b)(6): fd-410lr.
|